FDA Approved: TRIUMEQ PD — Original Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved TRIUMEQ PD, a fixed-dose combination of abacavir, dolutegravir, and lamivudine, under an Original Application for pediatric patients with HIV-1 inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRIUMEQ PD (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE)

Snippet

ORIG AP for TRIUMEQ PD (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE)